Adjunct professor, MD, Gynecologic oncologist Johanna Hynninen - UTU Research Portal

Johanna Hynninen
Adjunct professor, MD, Gynecologic oncologist

- Docent,
Department of Clinical Medicine (Faculty of Medicine)
- ,
Obstetrics and Gynaecology (Department of Clinical Medicine)

mijohy@utu.fi

: https://orcid.org/0000-0002-0854-7225

gynaecologic oncology; ovarian cancer

https://sites.utu.fi/ovariancancer/ https://www.deciderproject.eu

4 of 5

PET/CT for Evaluation of Ovarian Cancer (2019)
- Seminars in Nuclear Medicine
Jukka Kemppainen, Johanna Hynninen, Johanna Virtanen, Marko Seppänen
Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer (2019)
- JCO Precision Oncology
Oikkonen J, Zhang KY, Salminen L, Schulman I, Lavikka K, Andersson N, Ojanperä E, Hietanen S, Grenman S, Lehtonen R, Huhtinen K, Carpen O, Hynninen J, Färkkilä A, Hautaniemi S
Virtual clinical trials identify effective combination therapies in ovarian cancer (2019)
- Scientific Reports
Kozlowska E, Vallius T, Hynninen J, Hietanen S, Farkkila A, Hautaniemi S
A cancer-specific detection of serum CA125 improves differential diagnosis of epithelial ovarian cancer from benign conditions. (2018)
- Clinical Cancer Research
Huhtinen K, Gidwani K, Kekki H, Hynninen J, Salminen L, Perheentupa A, Poutanen M, Auranen A, Grenman S, Lamminmaki U, Carpen O, Pettersson K
A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients (2018)
- Clinical Cancer Research
Tumiati M, Hietanen S, Hynninen J, Pietilä E, Färkkilä A, Kaipio K, Roering P, Huhtinen K, Alkodsi A, Li Y, Lehtonen R, Erkan EP, Tuominen MM, Lehti K, Hautaniemi SK, Grénman S, Vähärautio A, Carpén O, Kauppi L
CA125 glycoform assay improves the performance of conventional CA125 in the diagnostics of epithelial ovarian cancer (2018)
- International Journal of Gynecological Cancer
Salminen L, Gidwani K, Rolfsen AL, Nadeem N, Bolstad N, Dorum A, Grenman S, Hietanen S, Perheentupa A, Poutanen M, Carpen O, Lamminmaki U, Pettersson K, Hynninen J, Huhtinen K
Clinical Value of F-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer (2018)
- Clinical Oncology
J. Hynninen, M. Laasik, T. Vallius, J. Kemppainen, S. Grönroos, J. Virtanen, J. Casado, S. Hautaniemi, S. Grenman, M. Seppänen, A. Auranen
Development of a cloud-based machine learning system (CLOBNET) to predict platinum resistance in high-grade serous ovarian cancer (2018)
- Clinical Cancer Research
Isoviita VM, Salminen L, Azar J, Hynninen J, Lehtonen R, Roring P, Grenman S, Farkkila A, Hautaniemi S
Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines. (2018)
- Clinical Cancer Research
Roering P, Mikkonen P, Potdar S, Wennerberg K, Hynninen J, Grenman S, Auranen A, Carpen O, Kaipio K
F-18-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer (2018)
- European Journal of Nuclear Medicine and Molecular Imaging
Vallius T, Hynninen J, Kemppainen J, Alves V, Auranen K, Matomäki J, Oksa S, Virtanen J, Grénman S, Auranen A, Seppänen M
Gynekologiset syövät (2018) Kliinisen fysiologian ja isotooppilääketieteen perusteet Johanna Hynninen, Johanna Virtanen, Marko Seppänen
High-throughput screening of new potential targets for high-grade serous ovarian cancer treatment (2018)
- Clinical Cancer Research
Dai J, Erkan EP, Zhang KY, Kaipio K, Lamminen T, Huhtinen K, Hynninen J, Grenman S, Carpen OM, Hautaniemi S, Vaharautio A
Identifying differentially methylated sites in samples with varying tumor purity (2018)
- Bioinformatics
Antti Häkkinen, Amjad Alkodsi, Chiara Facciotto, Kaiyang Zhang, Katja Kaipio, Sirpa Leppä, Olli Carpén, Seija Grénman, Johanna Hynninen, Sakari Hietanen Rainer Lehtonen, Sampsa Hautaniemi
Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer (2018)
- Cancer Research
Emilia Kozłowska, Anniina Färkkilä, Tuulia Vallius, Olli Carpén, Jukka Kemppainen, Seija Grénman, Rainer Lehtonen, Johanna Hynninen, Sakari Hietanen, Sampsa Hautaniemi
Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells (2017)
- Molecular and Cellular Proteomics
Nguyen Elizabeth V, Huhtinen Kaisa, Goo Young Ah, Kaipio Katja, Andersson Noora, Rantanen Ville, Hynninen Johanna, Lahesmaa Riitta, Carpen Olli, Goodlett David R
Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer (2017)
- Tumor Biology
Vallius T, Hynninen J, Auranen A, Matomaki J, Oksa S, Roering P, Grenman S
Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Mullerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors (2017)
- Gynecologic Oncology
Haltia UM, Hallamaa M, Tapper J, Hynninen J, Alfthan H, Kalra B, Ritvos O, Heikinheimo M, Unkila-Kallio L, Perheentupa A, Farkkila A
Uusi lektiini-avusteinen määrityskonsepti parantamaan CA-125-kasvainmerkkiaineen munasarjasyöpäspesifisyyttä (2017)
- Kliin lab
Kekki H, Gidwani K, Huhtinen K, Hynninen J, Pettersson K
(18)F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer (2016)
- Gynecologic Oncology
Vallius T, Peter A, Auranen A, Carpén O, Kemppainen J, Matomäki J, Oksa S, Roering P, Seppänen M, Grénman S, Hynninen J
A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources (2016)
- Clinical Chemistry
Gidwani Kamlesh, Huhtinen Kaisa, Kekki Henna, van Vliet Sandra, Hynninen Johanna, Koivuviita Niina, Perheentupa Antti, Poutanen Matti, Auranen Annika, Grenman Seija, Lamminmaki Urpo, Carpen Olli, van Kooyk Yvette, Pettersson Kim